Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Belle Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Belle Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 43 · Grade C

Belle Health

Visit Belle Health Full brief →

FDA warning letter, February 2026 — issued to Belle Health LLC dba Belle. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 79 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Belle Health a bad call — it's best for readers comparing longer supply plans who want named pharmacy partners and included nutrition support. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
78
Supply Reliability
95
73
Transparency
90
88
Access Breadth
93
90
Clinical Oversight
92
87
Track Record
88
52
CoreAge RxBrief Score 94 · 79Belle Health

Price, coverage & the tracker

CoreAge RxBelle Health
Brief Score94/100 (A)79/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$199 for a 1-month supply; $93/mo with a 12-month supply (payment schedule unconfirmed)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$249 for a 1-month supply; $179/mo with a 12-month supply (payment schedule unconfirmed)

CoverageUS only; restrictions by state, confirmed at intakeAll 50 states and D.C. advertised; treatment and pharmacy availability vary
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Belle Health: One-month supplies are listed at $199 semaglutide or $249 tirzepatide. Lower monthly equivalents require longer supplies; confirm payment timing and refund limits.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.